Skip to main content

Table 1 Changes in diabetes medication of 19 overweight participants with type 2 diabetes who underwent a 16-week diet intervention trial. Patients were provided with VLCKD counseling with an initial goal of <20 g carbohydrate/day. Medication was reduced at diet initiation. Data from Yancy, et al. [62].

From: Dietary carbohydrate restriction in type 2 diabetes mellitus and metabolic syndrome: time for a critical appraisal

Patient number

Daily Dose – Week 0

Daily Dose – Week 16

Medications discontinued (n = 7 of 19 originally on medication)

5

glipizide 10 mg

none

 

metformin 1000 mg

 

6

metformin 1500 mg

none

7

 

none

9

metformin 1000 mg

none

15

metformin 1000 mg

none

22

metformin 1000 mg

none

24

metformin 1000 mg

none

Medications reduced (n = 10 of 19)

3

70/30 insulin 50 units

metformin 1000 mg

 

metformin 1000 mg

 

11

metformin 2000 mg

metformin 2000 mg

 

glyburide 20 mg

 

16

metformin 2000 mg

metformin 2000 mg

 

pioglitazone 45 mg

 
 

glypizide 20 mg

 

21

metformin 1500 mg

metformin 1000 mg

 

pioglitazone 30 mg

 

8

NPH 145 units

NPH 25 units

 

metformin 1000 mg

metformin 1000 mg

13

70/30 insulin 70 units

70/30 insulin 35 units

 

metformin 2550 mg

metformin 2550 mg

23

70/30 insulin 110 units

70/30 insulin 80 units

 

pioglitazone 45 mg

pioglitazone 45 mg

  

metformin 1000 mg

25

NPH 70 units, r 30 units

NPH 8 units

 

metformin 2000 mg

metformin 2000 mg

 

pioglitazone 45 mg

pioglitazone 45 mg

27

70/30 insulin 86 units

70/30 insulin 18 units

 

metformin 2000 mg

metformin 2000 mg

28

NPH insulin 90 units

NPH insulin 30 units

 

lispro insulin 90 units

glypizide 20 mg

 

glypizide 20 mg